SD

Sarjan Dilip Shah

Active Director Director DIN 02212781
DIN 02212781 First appointment Nov 2010 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Nov 2010
Shareholding value •••• Premium profile

About Sarjan Dilip Shah

Data last updated:

Sarjan Dilip Shah is a Director at Green Cross Pathology Laboratory Private Limited (since 2019) and Designated Partner at Ratnakar Realty Llp (since 2017). The companies operate in Healthcare, Real Estate and Construction and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹1.13 Cr; the largest is Green Cross Pathology Laboratory Private Limited at ₹1.06 Cr (FY 2025). Earlier, Sarjan Dilip Shah was a Director at Green Cross Genetics Lab Private Limited (2014–2025) and Director at Ratnakar Realty Private Limited (2010–2017).

DIN 02212781
Primary Designation Director
Industry Healthcare
First Appointment 02 Nov 2010
Oldest Company Age 8 yrs
Largest company Green Cross Pathology Laboratory Private Limited · ₹1.06 Cr (FY 2025)
Combined revenue ₹1.13 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 May 20192019₹1.06 Cr (FY 2025)Active
Designated Partner29 Nov 20172017₹7 Lakh (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jun 20142014₹13.25 Cr (FY 2022)Active
Ratnakar Realty Private Limited U45201GJ1997PTC032650
Director02 Nov 20101997₹4.9 Lakh (FY 2017)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Green Cross Pathology Laboratory Private Limited
Ratnakar Realty Llp
Green Cross Genetics Lab Private Limited
Ratnakar Realty Private Limited
Premium access

Shareholding and investment profile for Sarjan Dilip Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarjan Dilip Shah

Sarjan Dilip Shah currently holds 2 directorships: Green Cross Pathology Laboratory Private Limited (Director, since 01 May 2019, revenue ₹1.06 Cr (FY 2025)); Ratnakar Realty Llp (Designated Partner, since 29 Nov 2017, revenue ₹7 Lakh (FY 2023)).

Sarjan Dilip Shah was first appointed on 02 Nov 2010 as Director at Ratnakar Realty Private Limited. The most recent appointment on record is 01 May 2019 at Green Cross Pathology Laboratory Private Limited.

The 2 current companies of Sarjan Dilip Shah that report revenue have a combined latest revenue of ₹1.13 Cr: Green Cross Pathology Laboratory Private Limited ₹1.06 Cr (FY 2025); Ratnakar Realty Llp ₹7 Lakh (FY 2023).

Sarjan Dilip Shah held 2 earlier board appointments: Green Cross Genetics Lab Private Limited (Director, 28 Jun 2014 to 03 Nov 2025); Ratnakar Realty Private Limited (Director, 02 Nov 2010 to 28 Nov 2017).

The current boards of Sarjan Dilip Shah's companies include Amarjeetkaur Adarshjitsingh (Green Cross Pathology Laboratory Private Limited), Amit Maniar (Green Cross Pathology Laboratory Private Limited), Chandresh Khengarji Chauhan (Green Cross Pathology Laboratory Private Limited), Chintan Vinodbhai Shah (Green Cross Pathology Laboratory Private Limited), Dhiren Madhusudan Shah (Green Cross Pathology Laboratory Private Limited), Dhiren Shukla (Green Cross Pathology Laboratory Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available